{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:34:12Z","timestamp":1790152452137,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T00:00:00Z","timestamp":1355270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1038\/ejhg.2012.273","type":"journal-article","created":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T11:37:36Z","timestamp":1355312256000},"page":"824-830","source":"Crossref","is-referenced-by-count":39,"title":["Angiogenetic axis angiopoietins\/Tie2 and VEGF in familial breast cancer"],"prefix":"10.1038","volume":"21","author":[{"given":"K","family":"Danza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Pilato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Lacalamita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Addati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Giotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Paradiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Tommasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,12]]},"reference":[{"key":"BFejhg2012273_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/35025215","volume":"407","author":"GD Yancopoulos","year":"2000","unstructured":"Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J : Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242\u2013248.","journal-title":"Nature"},{"key":"BFejhg2012273_CR2","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1002\/cncr.26540","volume":"118","author":"SE Abdullah","year":"2011","unstructured":"Abdullah SE, Perez-Soler R : Mechanisms of resistance to vascular endothelial growth factor blockade. Cancer 2011; 118: 3455\u20133467.","journal-title":"Cancer"},{"key":"BFejhg2012273_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrc2894","volume":"10","author":"H Huang","year":"2010","unstructured":"Huang H, Bhat A, Woodnutt G, Lappe R : Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer 2010; 10: 575\u2013585.","journal-title":"Nat Rev Cancer"},{"key":"BFejhg2012273_CR4","first-page":"387","volume":"25","author":"S Fukuhara","year":"2010","unstructured":"Fukuhara S, Sako K, Noda K, Zhang J, Minami M, Mochizuki N : Angiopoietin-1\/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol Histopathol 2010; 25: 387\u2013396.","journal-title":"Histol Histopathol"},{"key":"BFejhg2012273_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1365-2559.2011.03920.x","volume":"59","author":"CA Staton","year":"2011","unstructured":"Staton CA, Hoh L, Baldwin A et al: Angiopoietins 1 and 2 and Tie-2 receptor expression in human ductal breast disease. Histopathology 2011; 59: 256\u2013263.","journal-title":"Histopathology"},{"key":"BFejhg2012273_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10549-005-9157-9","volume":"98","author":"S Tsutsui","year":"2006","unstructured":"Tsutsui S, Inoue H, Yasuda K et al: Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and microvessel density. Breast Cancer Res Treat 2006; 98: 261\u2013266.","journal-title":"Breast Cancer Res Treat"},{"key":"BFejhg2012273_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.biocel.2009.11.020","volume":"42","author":"A Vassilopoulos","year":"2010","unstructured":"Vassilopoulos A, Deng CX, Chavakis T : Crosstalk between the DNA damage response, histone modifications and neovascularisation. Int J Biochem Cell Biol 2010; 42: 193\u2013197.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFejhg2012273_CR8","doi-asserted-by":"publisher","first-page":"7730","DOI":"10.1038\/sj.onc.1205971","volume":"21","author":"H Kawai","year":"2002","unstructured":"Kawai H, Li H, Chun P, Avraham S, Avraham HK : Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells. Oncogene 2002; 21: 7730\u20137739.","journal-title":"Oncogene"},{"key":"BFejhg2012273_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ccr.2006.05.022","volume":"10","author":"S Furuta","year":"2006","unstructured":"Furuta S, Wang JM, Wei S et al: Removal of BRCA1\/CtIP\/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculature. Cancer Cell 2006; 10: 13\u201324.","journal-title":"Cancer Cell"},{"key":"BFejhg2012273_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/145749690209100312","volume":"91","author":"H Eerola","year":"2002","unstructured":"Eerola H, Aittomaki K, Asko-Seljavaara S, Nevanlinna H, von Smitten K : Hereditary breast cancer and handling of patients at risk. Scand J Surg 2002; 91: 280\u2013287.","journal-title":"Scand J Surg"},{"key":"BFejhg2012273_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1471-2407-10-145","volume":"10","author":"MR Heerma van Voss","year":"2010","unstructured":"Heerma van Voss MR, van der Groep P, Bart J, van der Wall E, van Diest PJ : Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls. BMC Cancer 2010; 10: 145.","journal-title":"BMC Cancer"},{"key":"BFejhg2012273_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.5306\/wjco.v2.i9.329","volume":"2","author":"JD Davis","year":"2011","unstructured":"Davis JD, Lin SY : DNA damage and breast cancer. World J Clin Oncol 2011; 2: 329\u2013338.","journal-title":"World J Clin Oncol"},{"key":"BFejhg2012273_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.mrfmmm.2005.06.010","volume":"578","author":"S Tommasi","year":"2005","unstructured":"Tommasi S, Crapolicchio A, Lacalamita R et al: BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy. Mutat Res 2005; 578: 395\u2013405.","journal-title":"Mutat Res"},{"key":"BFejhg2012273_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1387\/ijdb.103212rm","volume":"55","author":"R Munoz-Chapuli","year":"2011","unstructured":"Munoz-Chapuli R : Evolution of angiogenesis. Int J Dev Biol 2011; 55: 345\u2013351.","journal-title":"Int J Dev Biol"},{"key":"BFejhg2012273_CR15","doi-asserted-by":"publisher","first-page":"13047","DOI":"10.1074\/jbc.M513033200","volume":"281","author":"HJ Kang","year":"2006","unstructured":"Kang HJ, Kim HJ, Rih JK et al: BRCA1 plays a role in the hypoxic response by regulating HIF-1alpha stability and by modulating vascular endothelial growth factor expression. J Biol Chem 2006; 281: 13047\u201313056.","journal-title":"J Biol Chem"},{"key":"BFejhg2012273_CR16","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/sj.bjc.6605287","volume":"101","author":"M Yan","year":"2009","unstructured":"Yan M, Rayoo M, Takano EA, Fox SB : BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression. Br J Cancer 2009; 101: 1168\u20131174.","journal-title":"Br J Cancer"},{"key":"BFejhg2012273_CR17","first-page":"3403","volume":"63","author":"L Zhang","year":"2003","unstructured":"Zhang L, Yang N, Park JW et al: Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res 2003; 63: 3403\u20133412.","journal-title":"Cancer Res"},{"key":"BFejhg2012273_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/01.MP.0000071841.17900.69","volume":"16","author":"WS Moon","year":"2003","unstructured":"Moon WS, Rhyu KH, Kang MJ et al: Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma? Mod Pathol 2003; 16: 552\u2013557.","journal-title":"Mod Pathol"},{"key":"BFejhg2012273_CR19","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3748\/wjg.v10.i9.1382","volume":"10","author":"XD Sun","year":"2004","unstructured":"Sun XD, Liu XE, Wu JM, Cai XJ, Mou YP, Li JD : Expression and significance of angiopoietin-2 in gastric cancer. World J Gastroenterol 2004; 10: 1382\u20131385.","journal-title":"World J Gastroenterol"},{"key":"BFejhg2012273_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/sj.cr.7290176","volume":"13","author":"LJ Metheny-Barlow","year":"2003","unstructured":"Metheny-Barlow LJ, Li LY : The enigmatic role of angiopoietin-1 in tumor angiogenesis. Cell Res 2003; 13: 309\u2013317.","journal-title":"Cell Res"},{"key":"BFejhg2012273_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.277.5322.55","volume":"277","author":"PC Maisonpierre","year":"1997","unstructured":"Maisonpierre PC, Suri C, Jones PF et al: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55\u201360.","journal-title":"Science"},{"key":"BFejhg2012273_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrm2639","volume":"10","author":"HG Augustin","year":"2009","unstructured":"Augustin HG, Koh GY, Thurston G, Alitalo K : Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009; 10: 165\u2013177.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"Suppl 1","key":"BFejhg2012273_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1634\/theoncologist.2011-S1-61","volume":"16","author":"CM Perou","year":"2011","unstructured":"Perou CM : Molecular stratification of triple-negative breast cancers. Oncologist 2011; 16 (Suppl 1): 61\u201370.","journal-title":"Oncologist"},{"key":"BFejhg2012273_CR24","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/annonc\/mdp062","volume":"20","author":"BK Linderholm","year":"2009","unstructured":"Linderholm BK, Hellborg H, Johansson U et al: Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer. Ann Oncol 2009; 20: 1639\u20131646.","journal-title":"Ann Oncol"},{"key":"BFejhg2012273_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3324\/haematol.11852","volume":"93","author":"K Anargyrou","year":"2008","unstructured":"Anargyrou K, Terpos E, Vassilakopoulos TP et al: Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory\/resistant multiple myeloma patients treated with bortezomib. Haematologica 2008; 93: 451\u2013454.","journal-title":"Haematologica"},{"key":"BFejhg2012273_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/pros.20163","volume":"62","author":"AJ Lind","year":"2005","unstructured":"Lind AJ, Wikstrom P, Granfors T, Egevad L, Stattin P, Bergh A : Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer. Prostate 2005; 62: 394\u2013399.","journal-title":"Prostate"},{"key":"BFejhg2012273_CR27","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1182\/blood-2009-11-252494","volume":"116","author":"R Maffei","year":"2010","unstructured":"Maffei R, Martinelli S, Santachiara R et al: Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. Blood 2010; 116: 584\u2013592.","journal-title":"Blood"},{"key":"BFejhg2012273_CR28","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/ijc.10851","volume":"103","author":"C Sfiligoi","year":"2003","unstructured":"Sfiligoi C, de Luca A, Cascone I et al: Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival. Int J Cancer 2003; 103: 466\u2013474.","journal-title":"Int J Cancer"},{"key":"BFejhg2012273_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1477-7800-4-6","volume":"4","author":"KA Rmali","year":"2007","unstructured":"Rmali KA, Watkins G, Douglas-Jones A, Mansel RE, Jiang WG : Angiopoietins lack of prognostic significance in ductal mammary carcinoma. Int Semin Surg Oncol 2007; 4: 6.","journal-title":"Int Semin Surg Oncol"},{"key":"BFejhg2012273_CR30","first-page":"7094","volume":"60","author":"SH Ali","year":"2000","unstructured":"Ali SH, O'Donnell AL, Balu D et al: Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis. Cancer Res 2000; 60: 7094\u20137098.","journal-title":"Cancer Res"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2012273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2012273","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2012273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:07:05Z","timestamp":1684429625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2012273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,12]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["BFejhg2012273"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2012.273","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,12]]}}}